Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Journal of Korean Medical Science ; : 535-541, 2016.
Article Dans Anglais | WPRIM | ID: wpr-122517

Résumé

Angiotensin II (Ang II) induces the pathological process of vascular structures, including renal glomeruli by hemodynamic and nonhemodynamic direct effects. In kidneys, Ang II plays an important role in the development of proteinuria by the modification of podocyte molecules. We have previously found that Ang II suppressed podocyte AMP-activated protein kinase (AMPK) via Ang II type 1 receptor and MAPK signaling pathway. In the present study, we investigated the roles of AMPK on the changes of p130Cas of podocyte by Ang II. We cultured mouse podocytes and treated them with various concentrations of Ang II and AMPK-modulating agents and analyzed the changes of p130Cas by confocal imaging and western blotting. In immunofluorescence study, Ang II decreased the intensity of p130Cas and changed its localization from peripheral cytoplasm into peri-nuclear areas in a concentrated pattern in podocytes. Ang II also reduced the amount of p130Cas in time and dose-sensitive manners. AMPK activators, metformin and AICAR, restored the suppressed and mal-localized p130Cas significantly, whereas, compound C, an AMPK inhibitor, further aggravated the changes of p130Cas. Losartan, an Ang II type 1 receptor antagonist, recovered the abnormal changes of p130Cas suppressed by Ang II. These results suggest that Ang II induces the relocalization and suppression of podocyte p130Cas by the suppression of AMPK via Ang II type 1 receptor, which would contribute to Ang II-induced podocyte injury.


Sujets)
Animaux , Souris , AMP-Activated Protein Kinases/antagonistes et inhibiteurs , 5-Amino-imidazole-4-carboxamide/analogues et dérivés , Angiotensine-II/pharmacologie , Antagonistes du récepteur de type 1 de l'angiotensine-II/pharmacologie , Technique de Western , Lignée cellulaire , Noyau de la cellule/métabolisme , Protéine BCAR1/métabolisme , Cytoplasme/métabolisme , Focal adhesion kinase 1/métabolisme , Losartan/pharmacologie , Metformine/pharmacologie , Microscopie confocale , Podocytes/cytologie , Inhibiteurs de protéines kinases/pharmacologie , Ribonucléotides/pharmacologie , Transduction du signal/effets des médicaments et des substances chimiques
SÉLECTION CITATIONS
Détails de la recherche